1.Effects of allergens on the expression of blood basophil activation markers in patients with allergic rhinitis.
Qiuli WANG ; Weihua XU ; Fangqiu GU ; Siqin WANG ; Junling WANG
Chinese Journal of Cellular and Molecular Immunology 2025;41(9):810-817
Objective To investigate the expression of blood basophil activation markers in patients with allergic rhinitis (AR) and the effects of allergens on their expression. Methods The blood samples were collected from the following four groups: healthy control (HC), AR patients with negative skin prick test (nAR), seasonal AR patients (sAR) and perennial AR patients (pAR). Flow cytometry was employed to analyze the expression of basophil activation markers Immunoglobulin E receptor I alpha(FcepsilonRIα), CD63 and CD203c in AR patients. Plasma levels of interleukin 4 (IL-4) and IL-8 were measured by liquid-phase chip technology, and their correlations with the percentages of activated basophils were further analyzed. An ovalbumin-induced AR mouse model was established, and the expression levels of FcepsilonRIα and CD63 on blood basophils were detected. Results The expression of FcepsilonRIα, CD203c and CD63 on basophils were increased in nAR, sAR and pAR patients. Allergens enhanced the mean florescence intensity expression of CD63 and CD203c on basophils of sAR and pAR patients. The plasma levels of IL-4 and IL-8 were elevated in nAR, sAR and pAR patients, showing moderate to high correlations with the expression levels of basophil activation markers. The FcepsilonRIαand CD63 expression on basophils of AR mice were increased. Conclusion Allergens may contribute to AR pathogenesis by upregulating the expression of FcepsilonRIα, CD63 and CD203c, as well as promoting the secretion of IL-4 and IL-8.
Basophils/metabolism*
;
Humans
;
Allergens/immunology*
;
Animals
;
Rhinitis, Allergic/blood*
;
Female
;
Male
;
Adult
;
Mice
;
Biomarkers/blood*
;
Tetraspanin 30/blood*
;
Interleukin-4/blood*
;
Interleukin-8/blood*
;
Receptors, IgE/blood*
;
Phosphoric Diester Hydrolases
;
Young Adult
;
Pyrophosphatases
;
Middle Aged
;
Mice, Inbred BALB C
2.Construction and Validation of a Prognostic Nomogram Model for Chronic Myeloid Leukemia Patients.
Li-Ying LIU ; Zheng GE ; Ji-Feng WEI ; Li-Na ZHAO ; Zhi-Mei CAI
Journal of Experimental Hematology 2025;33(3):745-752
OBJECTIVE:
To screen factors affecting the prognosis of chronic myeloid leukemia (CML) patients, and construct a nomogram model for event-free survival (EFS).
METHODS:
To screen out meaningful variables by univariate and multivariate Cox regression analysis in CML patients, and construct a nomogram model using R software. The nomogram was validated using consistency index (C-index), receiver operating characteristic (ROC) curve, area under the ROC curve (AUC), calibration curve, decision curve analysis (DCA), and risk stratification analysis.
RESULTS:
This study analyzed data from 116 CML patients. Univariate and multivariate Cox regression analysis demonstrated that age, peripheral blood basophil percentage, BCR-ABL1 IS at 3 months, and red blood cell distribution width (RDW) were independent prognostic factors of EFS. Subsequently, a nomogram was constructed based on the above predictors. The C-index of the nomogram was 0.733(95%CI : 0.676-0.790). The AUC values for predicting 1-, 3-, and 5-year EFS rate were 0.765, 0.855, and 0.827, respectively. The results of the calibration curve and DCA curve showed that the predictive model had good consistency, as well as strong clinical utility. The patients were stratified into high-risk group and low-risk group based on the total score of the model, there was a significant difference in EFS between the two groups (P < 0.001).
CONCLUSION
Age, peripheral blood basophil percentage, BCR-ABL1 IS at 3 months, and RDW were associated with the prognosis of CML patients. The nomogram model constructed in this study can accurately predict the prognostic status of CML patients, but its widespread application still requires external and prospective validation.
Nomograms
;
Leukemia, Myelogenous, Chronic, BCR-ABL Positive/mortality*
;
Proportional Hazards Models
;
Erythrocyte Indices
;
Risk Assessment/methods*
;
Fusion Proteins, bcr-abl/genetics*
;
Basophils
;
Leukocyte Count
;
Humans
3.Research advance on the role of interleukin-18, interleukin-37b and basophils in sepsis.
Junling WANG ; Xin DONG ; Mengmeng ZHAN ; Bingyu QIN
Chinese Critical Care Medicine 2025;37(1):77-80
Interleukin-18 (IL-18) and IL-37b have recently become a research hotspot because of their biological antagonistic role in inflammatory response. Sepsis is an abnormal inflammatory response-mediated life-threatening organ dysfunction induced by infection. Septic shock is the most severe form of sepsis, and has attracted great attention in clinical research due to its high mortality. Basophils are one of the classical effector cells in the inflammatory response, which are involved in many aspects of the pathological process of sepsis. IL-18 is an important pro-inflammatory cytokine and plays a key role in the inflammatory response, while IL-37b is known for its anti-inflammatory function. Both IL-18 and IL-37b can regulate the function of basophils and the inflammatory response in sepsis reversely through interleukin-18 receptor α (IL-18Rα). Therefore, it is of great clinical significance to investigate the role and mechanism of IL-18, IL-37b and basophils in the pathogenesis of sepsis. Herein, the relevant literatures on the roles and potential mechanisms of IL-18, IL-37b and basophils in the pathogenesis of sepsis are summarized, aiming to provide theoretical basis and novel ideas for the future research on the potential roles of IL-18, IL-37b and basophils in sepsis.
Humans
;
Sepsis/immunology*
;
Basophils/immunology*
;
Interleukin-18/metabolism*
;
Interleukin-1/metabolism*
;
Animals
4.Correlation between chronic sinusitis subtypes and basophil levels in peripheral blood.
Yuhui FAN ; Qingqing JIAO ; Aina ZHOU ; Jisheng LIU
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2023;37(4):293-301
Objective:To explore the clinical correlation between peripheral blood basophil levels and chronic sinusitis (CRS) subtypes. Methods:One hundred and twenty-six patients with CRS and 103 healthy cases from physical examination admitted to the First Affiliated Hospital of Soochow University from January 2021 to October 2022 were retrospectively analyzed. According to the histopathological classification, CRS patients were divided into eosinophilic chronic sinusitis (eCRS) group (47 cases) and non eosinophilic chronic sinusitis (non-eCRS) group (79 cases). The differences among the three groups in peripheral blood inflammation cell counts, eosinophils-to-basophils ratio(bEBR), basophils-to-neutrophils ratio(BNR), basophils-to-lymphocytes ratio(BLR), basophils-to-monocytes ratio(BMR) were compared, and study the correlation between each index and Lund-Mackay score, and the correlation between basophils in peripheral blood and other inflammatory cells. Results:The counts of basophils in the peripheral blood of the healthy control group, eCRS group and non-eCRS group were 0.03±0.01, 0.04±0.02, 0.03±0.02, respectively, the eosinophils-to-basophils ratio(bEBR) were 5.64±4.22, 8.38±5.95, 4.55±3.90, the basophils-to-neutrophils ratio(BNR) were 0.01±0, 0.01±0.01, 0.01±0.01, and the basophils-to-lymphocytes ratio(BLR) were 0.01±0.01, 0.02±0.01, and 0.02±0.01, respectively, the basophils-to-monocytes ratio(BMR) were 0.08±0.04, 0.11±0.06, and 0.08 ±0.04 respectively. There was a statistically significant difference between eCRS group and healthy control group, non-eCRS group(P<0.01), while there was no statistically significant difference between non-eCRS group and healthy control group(P>0.05). Basophil counts (r=0.185 5, P<0.05), BLR(r=0.226 9, P<0.05), BMR(r=0.228 1, P<0.01) in patients with CRS were positively correlated with Lund Makey score. In addition, basophils were also positively correlated with eosinophils(r=0.479 2, P<0.01), lymphocytes(r=0.259 4, P<0.01), and monocytes(r=0.256 4, P<0.01) in patients with CRS. Conclusion:The peripheral blood basophil count, BLR and BMR were significantly increased in eCRS, and were significantly positively correlated with Lund -Makey score. It has the potential to develop into disease biomarkers and new therapeutic targets of eCRS.
Humans
;
Basophils
;
Retrospective Studies
;
Rhinitis/surgery*
;
Eosinophils
;
Sinusitis/surgery*
;
Chronic Disease
;
Nasal Polyps/pathology*
5.Allergy to carminic acid: in vitro evidence of involvement of protein-binding hapten
Mika OSUMI ; Masao YAMAGUCHI ; Naoya SUGIMOTO ; Maho SUZUKAWA ; Hidenori ARAI ; Hiroshi AKIYAMA ; Hiroyuki NAGASE ; Ken OHTA
Asia Pacific Allergy 2019;9(1):e2-
We previously described a rare case of anaphylaxis presumably induced by carminic acid in cochineal dye used as a food additive. In this study, highly pure carminic acid was added to an albumin-containing buffer at various concentrations, followed by serial dilution. Varying the mixing ratio of carminic acid and albumin affected the extent of histamine release from passively sensitized basophils. Similar basophil histamine release occurred with carminic acid-globulin solutions. These results provide experimental evidence indicating that basophil activation is dependent on hapten (carminic acid) and carrier (protein) interaction.
Anaphylaxis
;
Basophils
;
Carmine
;
Food Additives
;
Histamine Release
;
Hypersensitivity
;
In Vitro Techniques
6.Signals from the various immune cells in promoting food allergy-induced eosinophilic esophagitis like disease
Priscilia LIANTO ; Yani ZHANG ; Huilian CHE
Asia Pacific Allergy 2019;9(3):e28-
Eosinophilic esophagitis (EoE) is a recently recognized esophageal inflammatory disease with clinical manifestations arising from esophageal dysfunction. The etiology of EoE is currently being clarified and food allergy is evolving as the central cornerstone of EoE disease pathogenesis. Given the large number of eosinophils in the esophagus of people with EoE verified by data from murine models EoE is widely considered as the hallmark T-helper type 2 (Th2) disease of the esophagus. It is also known that some eosinophilic inflammation is controlled by other subsets of T cells such as Th9 or Th17 and control is also exerted by type 2 innate lymphoid cells acting together with basophils. In this paper we review results from molecular studies of mouse models in light of the results from the first clinical trials targeting key cytokines in humans and present in-depth molecular understanding of EoE.
Animals
;
Basophils
;
Cytokines
;
Eosinophilic Esophagitis
;
Eosinophils
;
Esophagus
;
Food Hypersensitivity
;
Humans
;
Inflammation
;
Lymphocytes
;
Mice
;
T-Lymphocytes
7.Pollen/Fruit Syndrome: Clinical Relevance of the Cypress Pollen Allergenic Gibberellin-Regulated Protein.
Hélène SÉNÉCHAL ; Sanaz KEYKHOSRAVI ; Rémy COUDERC ; Marie Ange SELVA ; Youcef SHAHALI ; Tomoyasu AIZAWA ; Jean Marc BUSNEL ; Rihane ARIF ; Inna MERCIER ; Nhan PHAM-THI ; Denis André CHARPIN ; Pascal PONCET
Allergy, Asthma & Immunology Research 2019;11(1):143-151
A pollen/food-associated syndrome (PFAS) has been described between peach and cypress pollen. Cross-reactive allergens were characterized which belong to the Gibberellin-regulated protein (GRP) family, BP14 in cypress pollen and Pru p 7 in peach. GRP are small cationic protein with anti-microbial properties. A patient suffering from a peach/cypress syndrome was explored clinically and biologically using 2 types of immunoglobulin E (IgE) multiarray microchip, immunoblots and a basophil activation test to assess the clinical relevance of various extracts and purified allergens from fruits or cypress pollen. In addition to PR10 sensitization, the patient showed specific IgE to Pru p 7, BP14 and allergen from pomegranate. These last 3 allergens and allergenic sources are able to induce ex vivo basophil activation characterized by the monitoring of the expression of CD63 and CD203c, both cell surface markers correlated with a basophil mediator release. Up to 100% of cells expressed CD203c at 50 ng/mL of BP14 protein. In contrast, snakin-1, a GRP from potato sharing 82% sequence identity with Pru p 7 did not activate patient's basophils. These results strongly suggest that, like Pru p 7, BP14 is a clinically relevant allergenic GRP from pollen. Allergen members of this newly described protein family are good candidates for PFAS where no cross-reactive allergens have been characterized.
Allergens
;
Basophils
;
Cupressus*
;
Fruit
;
Humans
;
Immunoglobulin E
;
Immunoglobulins
;
Pollen*
;
Prunus persica
;
Punicaceae
;
Solanum tuberosum
8.Effects of Ser47-Point Mutation on Conformation Structure and Allergenicity of the Allergen of Der p 2, a Major House Dust Mite Allergen.
Bhakkawarat KULWANICH ; Sasipa THANYARATSRISAKUL ; Orathai JIRAPONGSANANURUK ; Belinda J. HALES ; Wayne R. THOMAS ; Surapon PIBOONPOCANUN
Allergy, Asthma & Immunology Research 2019;11(1):129-142
PURPOSE: Hypoallergenic recombinant Der p 2 has been produced by various genetic manipulations, but mutation of a naturally polymorphic amino acid residue known to affect IgE binding has not been studied. This study aimed to determine the effect of a point mutation (S47W) of residue 47 of Der p 2 on its structure and immunoglobulin (Ig) E binding. Its ability to induce pro-inflammatory responses and to induce blocking IgG antibody was also determined. METHODS: S47 of recombinant Der p 2.0110, one of the predominant variants in Bangkok, was mutated to W (S47W). S47W secreted from Pichia pastoris was examined for secondary structure and for the formation of a hydrophobic cavity by 8-Anilino-1-naphthalenesulfonic acid (ANS) staining. Monoclonal and human IgE-antibody binding was determined by enzyme-linked immunosorbent assay. Allergen-induced degranulation by human epsilon receptor expressed-rat basophil was determined. Stimulation of the pro-inflammatory cytokine interleukin (IL)-8 release from human bronchial epithelial (BEAS2B) cells and inhibition of IgE binding to the wild type allergen by S47W-induced IgG were determined. RESULTS: S47W reduced secondary structure and failed to bind the hydrophobic ANS ligand as well as a monoclonal antibody known to be dependent on the nature of the side chain of residue 114 in an adjacent loop. It could also not stimulate IL-8 release from BEAS2B cells. IgE from house dust mite (HDM)-allergic Thais bound S47W with 100-fold weaker avidity, whereas IgE of HDM-allergic Australians did not. S47W still induced basophil degranulation, although requiring higher concentrations for some subjects. Anti-S47W antiserum-immunized mice blocked the binding of human IgE to wild type Der p 2. CONCLUSIONS: The mutant S47W had altered structure and reduced ability to stimulate pro-inflammatory responses and to bind IgE, but retained its ability to induce blocking antibodies. It thus represents a hypoallergen produced by a single mutation of a non-solvent-accessible amino acid.
Animals
;
Antibodies, Blocking
;
Asian Continental Ancestry Group
;
Basophils
;
Dust*
;
Enzyme-Linked Immunosorbent Assay
;
Humans
;
Immunoglobulin E
;
Immunoglobulin G
;
Immunoglobulins
;
Interleukin-8
;
Interleukins
;
Mice
;
Pichia
;
Point Mutation
;
Pyroglyphidae*
9.Causal Relationship Between Anti-TPO IgE and Chronic Urticaria by In Vitro and In Vivo Tests.
Jorge SÁNCHEZ ; Andres SÁNCHEZ ; Ricardo CARDONA
Allergy, Asthma & Immunology Research 2019;11(1):29-42
PURPOSE: Immunoglobulin (Ig) E autoantibodies against thyroid antigens such as thyroid peroxidase (TPO) have been demonstrated in chronic spontaneous urticaria (CSU) patients in higher frequency than healthy subjects. However, if these IgE autoantibodies can trigger urticaria is still a matter of study. The aim of this study was to investigate the relationship between concomitant IgE autoantibodies against thyroid antigens in CSU. METHODS: Patients with CSU, healthy subjects and patients with autoimmune thyroid disease (ATD) were recruited. Total IgE and specific anti-TPO IgE and IgG were assessed in all subjects. The basophil activation test and skin tests with TPO were performed to demonstrate whether this antigen could selectively induce urticaria reaction in subjects with positive anti-TPO IgE. RESULTS: Anti-TPO IgE was present in all 3 groups (CSU: 34.0%, ATD: 16.6%, healthy subjects: 8.1%). Anti-TPO IgE levels were higher in CSU patients, whereas anti-TPO IgG were higher in ATD patients. After exposure to TPO, CD203c expression from patients with CSU and anti-TPO IgE significantly increased in comparison to the other groups; 33.0% vs. 14.0% in ATD patients and 9.0% in control subjects (P < 0.05). Skin reactions with TPO were higher in patients with CSU according to the intradermal (CSU: 18.0%, ATD: 3.3%, control: 8.0%) and skin prick tests (12.0%, 0%, 0%, respectively). Passive transfer of anti-TPO IgE from a CSU patient to the skin of control subjects without anti-TPO IgE induced a positive skin reaction. CONCLUSIONS: Anti-TPO IgE is not a specific biomarker for CSU. However, IgE against TPO plays a pathogenic role in inducing effector cell activation and skin exacerbation in some patients with CSU.
Autoantibodies
;
Autoimmunity
;
Basophils
;
Healthy Volunteers
;
Humans
;
Hypothyroidism
;
Immunoglobulin E*
;
Immunoglobulin G
;
Immunoglobulins
;
In Vitro Techniques*
;
Iodide Peroxidase
;
Skin
;
Skin Tests
;
Thyroid Diseases
;
Thyroid Gland
;
Urticaria*
10.Emerging Therapies in Chronic Spontaneous Urticaria
Allergy, Asthma & Immunology Research 2019;11(4):470-481
Chronic spontaneous urticaria (CSU) is characterized by typically short-lived and fleeting wheals, angioedema or both, which occur spontaneously and persist for longer than 6 weeks. This term is applied to the most common subtype of chronic urticaria. The underlying pathophysiology for CSU involves mast cell and basophil degranulation with release of histamine, leukotrienes, prostaglandins and other inflammatory mediators. Although a variety of treatments exist, many patients do not tolerate or benefit from the existing therapies and even require more effective treatments. Omalizumab is currently the only licensed biologic for antihistamine-refractory CSU, and novel drugs are under development. This article reviews its current status regarding pathogenesis and approach to treatment as well as therapeutic agents that are under development for the treatment of CSU.
Angioedema
;
Basophils
;
Biological Products
;
Histamine
;
Humans
;
Leukotrienes
;
Mast Cells
;
Omalizumab
;
Prostaglandins
;
Urticaria

Result Analysis
Print
Save
E-mail